Press Release From The Cancer Institute of New Jersey
October 12, 2006
Contact: Candace Botnick
732-235-9871
botnicca@umdnj.edu
The Cancer Institute of New Jersey
Announces 2006-2007 Distinguished Lecture Series
Thought-leaders at the forefront of cancer research among the list of speakers
New Brunswick — As one of only 39 National Cancer Institute-designated Comprehensive Cancer Centers in the nation and the only one in New Jersey, The Cancer Institute of New Jersey (CINJ) is a leader in cancer research, treatment and education. CINJ is dedicated to providing outstanding educational opportunities to learn about the latest in cancer research and treatment to the medical, scientific and general community.
The Annual CINJ Distinguished Lecture Series brings world-renown cancer experts to New Jersey to present their research and engage in discussion on the topic. Among this year’s list of speakers are: Dr. Derek Raghavan, M. Frank & Margaret Domiter Rudy Distinguished Chair & Director Cleveland Clinic Taussig Cancer Center; Dr. Gregory Verdine, Harvard College Professor and Erving Professor of Chemistry, Harvard University; and Dr. Irving Weissman, Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, Director, Comprehensive Cancer Center and Professor of Pathology and Developmental Biology, Department of Pathology, Stanford University School of Medicine.
A complete listing of speakers, topics and dates for the 2006-2007 CINJ Distinguished Lecture Series is below and can also be found at http://www.cinj.org/aboutcinj/contMedEdu.htm. All seminars are held at The Cancer Institute of New Jersey in New Brunswick and are free and open to the public and members of the media.
About CINJ
The Cancer Institute of New Jersey is New Jersey’s first and only National Cancer Institute-designated Comprehensive Cancer Center, and is dedicated to improving the prevention, detection, treatment and care of patients with cancer. CINJ’s physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice-quite literally bringing research to life. The Cancer Institute of New Jersey is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School. To support CINJ, please call The Cancer Institute of New Jersey Foundation at 732-235-8614.
The Cancer Institute of New Jersey Network is comprised of hospitals throughout the state and provides a mechanism to rapidly disseminate important discoveries into the community. Partner Hospitals: Robert Wood Johnson University Hospital, Atlantic Health System (Morristown Memorial Hospital, Mountainside Hospital, Overlook Hospital). Affiliate Hospitals: Bayshore Community Hospital, CentraState Healthcare System, Cooper University Hospital (CINJ at Cooper),* Jersey Shore University Medical Center, JFK Medical Center, Monmouth Medical Center, Raritan Bay Medical Center, Robert Wood Johnson University Hospital at Hamilton (CINJ-Hamilton), Saint Peter’s University Hospital, Somerset Medical Center, Southern Ocean County Hospital, The University Hospital/UMDNJ-New Jersey Medical School,* and University Medical Center at Princeton *Academic Affiliate
SPEAKER DATE PRESENTATION TITLE
Chung S Yang, PhD September 20, 2006 Cancer Prevention by Tea:
Professor II & Chair 5:00 PM Mechanisms and Human Relevance
Department of Chemical Biology
Rutgers, The State University of New Jersey
Derek Raghavan, MD, PhD, FACP, FRACP October 18, 2006 Bladder Cancer - Of Mice and Men
M. Frank & Margaret Domiter Rudy 5:00 PM
Distinguished Chair & Director
Cleveland Clinic Taussig Cancer Center
David Spriggs, MD November 15, 2006 Mucins, Markers and Biology: CA 15-3,
Head, Division of Solid Tumor Oncology 5:00 PM CA 125 and Beyond
Winthrop Rockefeller Chair in
Medical Oncology
Memorial Sloan-Kettering Cancer Center
Gregory Verdine, PhD December 20, 2006 Drugging the Undruggable
Harvard College Professor 5:00 PM
Erving Professor of Chemistry
Harvard University
Mary-Ann Bjornsti, PhD January 17, 2007 TOR Signaling in S-phase
Member, Department of Molecular 5:00 PM
Pharmacology
St. Jude Children’s Research Hospital
Frederick W. Alt, PhD February 21, 2007 NHEJ and the
Charles A. Janeway, Professor 5:00 PM Double-strand Break Response in IGH
of Pediatrics at Harvard Medical Class Recombination and
School, Investigator, Howard Hughes Translocations
Medical Institute at Children’s Hospital
and Scientific Director at CBR Institute
for Biomedical Research
Irving L. Weissman, MD March 28, 2007 Stems Cells and Cancer
Director, Stanford Institute for Stem 5:00 PM
Cell Biology and Regenerative Medicine
Director, Comprehensive Cancer Center
Professor of Pathology and Developmental
Biology, Department of Pathology
Stanford University School of Medicine
Todd R. Golub, MD April 25, 2007 Genomic Information and Cancer
Director, Cancer Program 5:00 PM
The Broad Institute of Harvard and
MIT, Charles A. Dana Investigator
Dana-Farber Cancer Institute and
Investigator, Howard Hughes Medical Institute
Steven F. Dowdy, PhD May 16, 2007 Mad Cows, Prions and TAT:
Investigator, Howard Hughes 5:00 PM Macromolecular Delivery of siRNAs
Medical Institute
Professor, Department of
Cellular & Molecular Medicine, University of California
Peter M. Glazer, MD, PhD June 20, 2007 Hypoxia, DNA Repair, and
Robert E. Hunter Professor of Radiology 5:00 PM Cancer Therapy
Chairman, Department of Therapeutic Radiology
Professor, Department of Genetics
Yale University School of Medicine
|
